scholarly journals Evaluation of the initial optical coherence tomography parameters in anticipating the final visual outcome of central retinal vein occlusion

2020 ◽  
Vol 32 (1) ◽  
pp. 46
Author(s):  
MuhammetDerda Ozer ◽  
Muhammed Batur ◽  
Selma Mesen ◽  
Serek Tekin ◽  
Erbil Seven
Keyword(s):  
Optical Coherence Tomography ◽  
Retinal Vein Occlusion ◽  
Central Retinal Vein Occlusion ◽  
Visual Outcome ◽  
Optical Coherence ◽  
Vein Occlusion ◽  
Central Retinal Vein ◽  
Final Visual Outcome

scholarly journals TO ASSESS REDUCTION IN MACULAR EDEMA BY SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY (SD-OCT) FOLLOWING INJECTION OF BEVACIZUMAB IN CASES OF CENTRAL RETINAL VEIN OCCLUSION (CRVO)

2021 ◽  
Vol 9 (08) ◽  
pp. 347-351
Author(s):  
Manjula Patnana ◽  
◽  
Nirmala Jyothi Pamu ◽  
Shashwati Bhushan ◽  
Ramakrishna Chatti ◽  
...  
Keyword(s):  
Optical Coherence Tomography ◽  
Macular Edema ◽  
Retinal Vein Occlusion ◽  
Central Retinal Vein Occlusion ◽  
Macular Oedema ◽  
Spectral Domain ◽  
Optical Coherence ◽  
Vein Occlusion ◽  
Central Retinal Vein ◽  
Sd Oct

Aim: To study the reduction in macular oedema in Central Retinal Vein Occlusion cases following Intravitreal injection of Bevacizumab using Spectral Domain Optical Coherence Tomography. Methods: 50 patients diagnosed with Central Retinal Vein Occlusion with macular oedema of more than 300 microns on Spectral Domain Optical Coherence Tomography ( SD-OCT) ,who attended to Out patient Department of Government Regional Eye Hospital (GREH) between January 2020 to June 2020 were administered Intravitreal Injection of Bevacizumab (Avastin) 1.25mg in 0.05ml. Re-injections were given if SD-OCT showed persistence of macular oedema. In follow up visits, patients were evaluated with SD-OCT and Central macular thickness (CMT) was measured every month till 6 months from the date of first injection. Results: Out of 50 cases included in the study, there was reduction in macular oedema in 45 (90%) cases and 5% had persistence of macular edema. Conclusion: Intravitreal Bevacizumab is a safe and effective modality of treatment for reducing macular edema due to Central Retinal Vein Occlusion as per our study.

scholarly journals Fluorescein angiography, optic coherence tomography, and optic coherence tomography angiography in central retinal vein occlusion and macular edema

2019 ◽  
pp. 21-25
Keyword(s):  
Optical Coherence Tomography ◽  
Fluorescein Angiography ◽  
Macular Edema ◽  
Retinal Vein Occlusion ◽  
Central Retinal Vein Occlusion ◽  
Circulation System ◽  
Optic Coherence Tomography ◽  
Optical Coherence ◽  
Vein Occlusion ◽  
Central Retinal Vein

Retinal vein occlusion (RVO) is one of the most common retinal vascular diseases. Macular edema (ME) is the most common reason for decreased visual acuity in RVO. Macular edema results from disruption of the blood-retinal barrier and subsequent accumulation of the leaking fluid leading to increased retinal thickness. Fundus fluorescein angiography (FFA) and optical coherence tomography (OCT) are commonly used for the diagnosis of macular edema. FFA identifies the anatomical location and pattern of vascular leakage and shows the retinal blood circulation system. OCT allows us to describe the morphological characteristics of macular edema and also to monitor the treatment response of ME to different drugs. Optical coherence tomography angiography (OCTA) is a new method that can visualize the vascular networks in separate layers of the retina in the macular region. In this paper, the authors aimed to review the evaluation of these three tests in ME secondary to central retinal vein occlusion (CRVO).

Sign in / Sign up

Export Citation Format

Share Document